Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada

Canada has become the first country to fully approve Johnson & Johnson's JNJ single-dose Covid-19 vaccine. According to a statement, regulators based their decision on the Phase 3 ENSEMBLE study, which showed an 85% efficacy against severe disease.

• The move comes after Health Canada granted full approval to the Pfizer Inc PFE / BioNTech SE BNTX and Moderna Inc MRNA vaccines in September. 
• The rollout of J&J's vaccine in Canada was slower than expected after it was discovered that the country's first shipment of doses had been processed at the Emergent BioSolutions Inc EBS plants, according to CBC News. 
• Earlier this month, Health Canada authorized booster doses of the Pfizer and Moderna vaccines but has yet to give a green signal to JNJ's booster shot.
• Also Read: Millions Of JNJ COVID-19 Shots Sit Idle At Emergent's Baltimore Plant: Reuters.
• Price Action: JNJ shares are down 0.09% at $160.54 during the market session on the last check Wednesday.
• Photo by Spencer Davis from Pixabay